Published

Psilocybin for treating substance use disorders?

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Expert review of neurotherapeutics
Date: 2017-02-01
Source: PubMed
DOI: 10.1080/14737175.2016.1220834
PubMed: 27684102

Authors

de Veen BT Schellekens AF Verheij MM Homberg JR

Watch author

Derived topics and classifications

psilocybin Depression Addiction Mechanism of Action Receptor Pharmacology Emotional Processing Review Article Safety Toxicity Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 6 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus2026-05-07 Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey2026-04-15 Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling2023-03-01 Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin2021-01-01 Psilocybin for treating substance use disorders?2017-02-01 Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance2017-01-02

Related papers

Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapyJournal of Psychedelic Studies · 2026-08-13 Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.Open MIND · 2026-07-09 Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of DepressionZenodo (CERN European Organization for Nuclear Research) · 2026-07-17 Psychedelic Therapies in the Management of Post-Traumatic Stress DisorderJournal of Education Health and Sport · 2026-07-16 Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer CareUnknown journal · 2026-08-17 Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01 Therapeutic potential of classic and non-classic psychedelics in neurodevelopmental disorders: Opportunities and challenges.Pharmacological research · 2026-08-06